Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Andrew Dickinson
Age : 50
Public asset : 2,545,823 USD
Country of residence : Unknown
Linked companies : Gilead Sciences, Inc. - Immunomedics, Inc. - Forty Seven, Inc.

Biography of Andrew Dickinson 
Mr. Andrew D. Dickinson is a President, Treasurer & Director at Immunomedics, Inc., a President, Treasurer & Director at Forty Seven, Inc. and a Chief Financial Officer at Gilead Sciences, Inc. He is on the Board of Directors at Immunomedics, Inc., Forty Seven, Inc., Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. Mr. Dickinson was previously employed as a Founding Partner by Kendall Dickinson & Koenig LLC, a Secretary, Vice President & General Counsel by Myogen, Inc., and a Co-Head-Healthcare Investment Banking by Lazard Ltd. He received his undergraduate degree from The University of Colorado and a graduate degree from Loyola University of Chicago.


Current positions of Andrew Dickinson 
Holdings of Andrew Dickinson 
Andrew Dickinson : Personal Network 
Most Read News 
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
07/27JIN SHI : Philippines says close to sale of former Hanjin shipyard
RE
More news


© 2021 People and Ownership :   
Andrew Dickinson : Connections 


Latest news about Andrew Dickinson 
2020GILEAD SCIENCES : cuts 2020 sales outlook as COVID-19 drug remdesivir falls short
RE
2020Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update
DJ
2019Gilead Sciences, Inc. Appoints Andrew Dickinson as Chief Financial Officer, Effective November 1, 2019
CI
2018Gilead Sciences, Inc. Announces Executive Changes
CI
2017Gilead Sciences, Inc. completed the acquisition of Kite Pharma, Inc..
CI
2017Gilead Sciences, Inc. entered into a definitive agreement to acquire Kite Pharma, Inc. for $10.4 billion.
CI
More news